ID   CHSS2_HUMAN             Reviewed;         775 AA.
AC   Q8IZ52; B4DXU0; Q6UXD6; Q7L4G1; Q9H0F8; Q9H618;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 132.
DE   RecName: Full=Chondroitin sulfate synthase 2;
DE            EC=2.4.1.175;
DE            EC=2.4.1.226;
DE   AltName: Full=Chondroitin glucuronyltransferase 2;
DE   AltName: Full=Chondroitin-polymerizing factor;
DE            Short=ChPF;
DE   AltName: Full=Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II;
DE   AltName: Full=N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II;
DE   AltName: Full=N-acetylgalactosaminyltransferase 2;
GN   Name=CHPF; Synonyms=CSS2; ORFNames=UNQ651/PRO1281;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH CHSY1, TISSUE
RP   SPECIFICITY, AND VARIANT ARG-371.
RX   PubMed=12716890; DOI=10.1074/jbc.M302493200;
RA   Kitagawa H., Izumikawa T., Uyama T., Sugahara K.;
RT   "Molecular cloning of a chondroitin polymerizing factor that
RT   cooperates with chondroitin synthase for chondroitin polymerization.";
RL   J. Biol. Chem. 278:23666-23671(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR, TISSUE
RP   SPECIFICITY, AND VARIANT ARG-371.
RX   PubMed=12761225; DOI=10.1074/jbc.M303657200;
RA   Yada T., Gotoh M., Sato T., Shionyu M., Go M., Kaseyama H.,
RA   Iwasaki H., Kikuchi N., Kwon Y.-D., Togayachi A., Kudo T.,
RA   Watanabe H., Narimatsu H., Kimata K.;
RT   "Chondroitin sulfate synthase-2. Molecular cloning and
RT   characterization of a novel human glycosyltransferase homologous to
RT   chondroitin sulfate glucuronyltransferase, which has dual enzymatic
RT   activities.";
RL   J. Biol. Chem. 278:30235-30247(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-371.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ARG-371.
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-371.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-371.
RC   TISSUE=Brain, Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 210-775, AND VARIANT
RP   ARG-371.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [9]
RP   ALTERNATIVE SPLICING, FUNCTION (ISOFORM 2), INTERACTION WITH PRKN,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22082830; DOI=10.1093/hmg/ddr530;
RA   Kuroda Y., Sako W., Goto S., Sawada T., Uchida D., Izumi Y.,
RA   Takahashi T., Kagawa N., Matsumoto M., Matsumoto M., Takahashi R.,
RA   Kaji R., Mitsui T.;
RT   "Parkin interacts with Klokin1 for mitochondrial import and
RT   maintenance of membrane potential.";
RL   Hum. Mol. Genet. 21:991-1003(2012).
CC   -!- FUNCTION: Has both beta-1,3-glucuronic acid and beta-1,4-N-
CC       acetylgalactosamine transferase activity. Transfers glucuronic
CC       acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc)
CC       from UDP-GalNAc to the non-reducing end of the elongating
CC       chondroitin polymer. Isoform 2 may facilitate PRKN transport into
CC       the mitochondria. In collaboration with PRKN, isoform 2 may
CC       enhance cell viability and protect cells from oxidative stress.
CC       {ECO:0000269|PubMed:12761225}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + beta-D-
CC       glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-proteoglycan =
CC       UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosyl-
CC       (1->3)-N-acetyl-beta-D-galactosaminyl-proteoglycan.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-beta-D-
CC       galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan = UDP +
CC       beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-
CC       beta-D-glucuronosyl-proteoglycan.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12761225};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:12761225};
CC       Note=Highest activities are measured with Mn(2+). Can also utilize
CC       Co(2+). {ECO:0000269|PubMed:12761225};
CC   -!- SUBUNIT: Binds CHSY1. Isoform 1, isoform 2 and isoform 3 interact
CC       with PRKN.
CC   -!- INTERACTION:
CC       O60260:PARK2; NbExp=5; IntAct=EBI-9029620, EBI-716346;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Golgi apparatus, Golgi stack
CC       membrane {ECO:0000305}; Single-pass type II membrane protein
CC       {ECO:0000305}. Cytoplasm, cytosol {ECO:0000269|PubMed:22082830}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:22082830}. Mitochondrion
CC       {ECO:0000269|PubMed:22082830}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Mitochondrion matrix
CC       {ECO:0000269|PubMed:22082830}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IZ52-1; Sequence=Displayed;
CC       Name=2; Synonyms=Klokin1;
CC         IsoId=Q8IZ52-2; Sequence=VSP_053433;
CC       Name=3; Synonyms=ChPF(D996);
CC         IsoId=Q8IZ52-4; Sequence=VSP_053434;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in pancreas,
CC       ovary, brain, heart, skeletal muscle, colon, kidney, liver,
CC       stomach, spleen and placenta. Isoform 3 is also ubiquitous.
CC       Isoform 2 is expressed in brain, spleen, ovary, testis, lung and
CC       peripheral mononuclear cells. {ECO:0000269|PubMed:12716890,
CC       ECO:0000269|PubMed:12761225, ECO:0000269|PubMed:22082830}.
CC   -!- SIMILARITY: Belongs to the chondroitin N-
CC       acetylgalactosaminyltransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB095813; BAC78393.1; -; mRNA.
DR   EMBL; AB086063; BAC81536.1; -; mRNA.
DR   EMBL; AY358403; AAQ88769.1; -; mRNA.
DR   EMBL; AK026331; BAB15449.1; -; mRNA.
DR   EMBL; AK302124; BAG63502.1; -; mRNA.
DR   EMBL; AC009955; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70768.1; -; Genomic_DNA.
DR   EMBL; BC008878; AAH08878.2; -; mRNA.
DR   EMBL; BC021223; AAH21223.2; -; mRNA.
DR   EMBL; BC023531; AAH23531.1; -; mRNA.
DR   EMBL; AL136814; CAB66748.2; -; mRNA.
DR   CCDS; CCDS2443.1; -. [Q8IZ52-1]
DR   CCDS; CCDS56169.1; -. [Q8IZ52-4]
DR   RefSeq; NP_001182660.1; NM_001195731.1.
DR   RefSeq; NP_078812.2; NM_024536.5.
DR   UniGene; Hs.516711; -.
DR   ProteinModelPortal; Q8IZ52; -.
DR   SMR; Q8IZ52; -.
DR   BioGrid; 122729; 10.
DR   IntAct; Q8IZ52; 11.
DR   MINT; MINT-1184453; -.
DR   STRING; 9606.ENSP00000243776; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   CAZy; GT7; Glycosyltransferase Family 7.
DR   iPTMnet; Q8IZ52; -.
DR   PhosphoSitePlus; Q8IZ52; -.
DR   BioMuta; CHPF; -.
DR   DMDM; 311033361; -.
DR   EPD; Q8IZ52; -.
DR   MaxQB; Q8IZ52; -.
DR   PaxDb; Q8IZ52; -.
DR   PeptideAtlas; Q8IZ52; -.
DR   PRIDE; Q8IZ52; -.
DR   DNASU; 79586; -.
DR   Ensembl; ENST00000243776; ENSP00000243776; ENSG00000123989. [Q8IZ52-1]
DR   Ensembl; ENST00000535926; ENSP00000445571; ENSG00000123989. [Q8IZ52-4]
DR   GeneID; 79586; -.
DR   KEGG; hsa:79586; -.
DR   UCSC; uc002vmc.5; human. [Q8IZ52-1]
DR   CTD; 79586; -.
DR   DisGeNET; 79586; -.
DR   GeneCards; CHPF; -.
DR   HGNC; HGNC:24291; CHPF.
DR   HPA; HPA035123; -.
DR   MIM; 610405; gene.
DR   neXtProt; NX_Q8IZ52; -.
DR   OpenTargets; ENSG00000123989; -.
DR   PharmGKB; PA162382245; -.
DR   eggNOG; KOG3708; Eukaryota.
DR   eggNOG; ENOG410XWZJ; LUCA.
DR   GeneTree; ENSGT00760000119143; -.
DR   HOGENOM; HOG000037934; -.
DR   HOVERGEN; HBG050941; -.
DR   InParanoid; Q8IZ52; -.
DR   KO; K00747; -.
DR   OMA; CTGDHEG; -.
DR   OrthoDB; EOG091G04Y5; -.
DR   PhylomeDB; Q8IZ52; -.
DR   TreeFam; TF318303; -.
DR   BioCyc; MetaCyc:HS13103-MONOMER; -.
DR   BRENDA; 2.4.1.175; 2681.
DR   BRENDA; 2.4.1.226; 2681.
DR   Reactome; R-HSA-2022870; Chondroitin sulfate biosynthesis.
DR   GeneWiki; CHPF; -.
DR   GenomeRNAi; 79586; -.
DR   PRO; PR:Q8IZ52; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000123989; -.
DR   CleanEx; HS_CHPF; -.
DR   ExpressionAtlas; Q8IZ52; baseline and differential.
DR   Genevisible; Q8IZ52; HS.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; TAS:Reactome.
DR   GO; GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome.
DR   InterPro; IPR008428; Chond_GalNAc.
DR   Pfam; PF05679; CHGN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Glycoprotein;
KW   Golgi apparatus; Membrane; Metal-binding; Mitochondrion; Polymorphism;
KW   Reference proteome; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    775       Chondroitin sulfate synthase 2.
FT                                /FTId=PRO_0000189560.
FT   TOPO_DOM      1     15       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     16     34       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     35    775       Lumenal. {ECO:0000255}.
FT   COMPBIAS    515    571       Ala-rich.
FT   METAL       617    617       Divalent metal cation. {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    361    361       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    460       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053433.
FT   VAR_SEQ       1    162       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053434.
FT   VARIANT     371    371       Q -> R (most frequent polymorphism;
FT                                dbSNP:rs6436155).
FT                                {ECO:0000269|PubMed:11230166,
FT                                ECO:0000269|PubMed:12716890,
FT                                ECO:0000269|PubMed:12761225,
FT                                ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_047394.
FT   CONFLICT    650    650       A -> G (in Ref. 3; AAQ88769).
FT                                {ECO:0000305}.
SQ   SEQUENCE   775 AA;  85467 MW;  94EDDB2481C97B70 CRC64;
     MRASLLLSVL RPAGPVAVGI SLGFTLSLLS VTWVEEPCGP GPPQPGDSEL PPRGNTNAAR
     RPNSVQPGAE REKPGAGEGA GENWEPRVLP YHPAQPGQAA KKAVRTRYIS TELGIRQRLL
     VAVLTSQTTL PTLGVAVNRT LGHRLERVVF LTGARGRRAP PGMAVVTLGE ERPIGHLHLA
     LRHLLEQHGD DFDWFFLVPD TTYTEAHGLA RLTGHLSLAS AAHLYLGRPQ DFIGGEPTPG
     RYCHGGFGVL LSRMLLQQLR PHLEGCRNDI VSARPDEWLG RCILDATGVG CTGDHEGVHY
     SHLELSPGEP VQEGDPHFRS ALTAHPVRDP VHMYQLHKAF ARAELERTYQ EIQELQWEIQ
     NTSHLAVDGD QAAAWPVGIP APSRPASRFE VLRWDYFTEQ HAFSCADGSP RCPLRGADRA
     DVADVLGTAL EELNRRYHPA LRLQKQQLVN GYRRFDPARG MEYTLDLQLE ALTPQGGRRP
     LTRRVQLLRP LSRVEILPVP YVTEASRLTV LLPLAAAERD LAPGFLEAFA TAALEPGDAA
     AALTLLLLYE PRQAQRVAHA DVFAPVKAHV AELERRFPGA RVPWLSVQTA APSPLRLMDL
     LSKKHPLDTL FLLAGPDTVL TPDFLNRCRM HAISGWQAFF PMHFQAFHPA VAPPQGPGPP
     ELGRDTGRFD RQAASEACFY NSDYVAARGR LAAASEQEEE LLESLDVYEL FLHFSSLHVL
     RAVEPALLQR YRAQTCSARL SEDLYHRCLQ SVLEGLGSRT QLAMLLFEQE QGNST
//
